Joint Corp Q1 rev $29.7M (+5% YoY), operating income $1.1M, reiterates guidance

JOINT Corp

2024-Q1 EPS reported $0.06 revenue$29,722,166

Revenue $29.7M (+5% YoY); operating income $1.1M vs loss $653k; net income $0.06/diluted share.
Adjusted EBITDA $3.5M (+75% from $2.0M); system-wide comp sales +3%.
Opened 23 franchised clinics; total clinic count 954; sold 15 franchise licenses, triple Q4 2023's 5.
FY 2024 guidance reiterated: system-wide sales $530-545M, new franchised openings 60-75 (excl. refranchising).
Hired investment bank specializing in refranchising to accelerate corporate clinic portfolio transition.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

JOINT Corp reported Q1 2024 results: revenue $29.7 million, net income $947,000, EPS $0.06 per diluted share. Guidance reaffirmed.

Period: Q1 2024
Revenue: $29.7 million
Net income: $947,000
EPS: $0.06 per diluted share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

franchisor of chiropractic clinics, reported its financial results for the quarter ended March 31, 2024. Financial Highlights: Q1 2024 Compared to Q1 2023 • Grew revenue 5% to $29.7 million. • Recorded operating income of $1.1 million, compared to operating loss of $653,000. • Reported net income of $947,000, compared to $2.3 million, including the receipt of the

View on SEC.gov

316 earnings releases filed in the last 30 days. Browse all earnings releases →

JOINT Corp filing history →

Source: SEC EDGAR

accession 0001612630-24-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.